Literature DB >> 24367837

Rubella and congenital rubella syndrome control and elimination – global progress, 2012.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24367837

Source DB:  PubMed          Journal:  Wkly Epidemiol Rec        ISSN： 0049-8114


× No keyword cloud information.
  3 in total

1.  Study protocol for a phase 1/2, single-centre, double-blind, double-dummy, randomized, active-controlled, age de-escalation trial to assess the safety, tolerability and immunogenicity of a measles and rubella vaccine delivered by a microneedle patch in healthy adults (18 to 40 years), measles and rubella vaccine-primed toddlers (15 to 18 months) and measles and rubella vaccine-naïve infants (9 to 10 months) in The Gambia [Measles and Rubella Vaccine Microneedle Patch Phase 1/2 Age De-escalation Trial].

Authors:  Ikechukwu Adigweme; Edem Akpalu; Mohammed Yisa; Simon Donkor; Lamin B Jarju; Baba Danso; Anthony Mendy; David Jeffries; Abdoulie Njie; Andrew Bruce; Michael Royals; James L Goodson; Mark R Prausnitz; Devin McAllister; Paul A Rota; Sebastien Henry; Ed Clarke
Journal:  Trials       Date:  2022-09-14       Impact factor: 2.728

2.  Hospital-based surveillance of congenital rubella syndrome in Indonesia.

Authors:  Elisabeth Siti Herini; Agung Triono; Asal Wahyuni Erlin Mulyadi; Niprida Mardin; Yati Soenarto; Susan E Reef
Journal:  Eur J Pediatr       Date:  2017-01-13       Impact factor: 3.860

3.  Rubella Immunity among Italian Female Healthcare Workers: A Serological Study.

Authors:  Luca Coppeta; Cristiana Ferrari; Ilaria Iannuzzi; Iacopo D'Alessandro; Ottavia Balbi; Antonio Pietroiusti; Marco Trabucco Aurilio
Journal:  Int J Environ Res Public Health       Date:  2020-10-30       Impact factor: 3.390
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.